Elevance Health (ELV) sued U.S. health officials saying Medicare was “arbitrary and capricious” in how it calculated its star ratings, costing the company at least $375M, John Tozzi of Bloomberg reports. The lawsuit was filed Thursday in federal court in the Northern District of Texas.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Molina Healthcare price target raised to $345 from $335 at Stephens
- Medicare paid insurers approx $4.2B for home diagnoses, WSJ reports
- 3 Best Stocks to Buy Now, 10/24/2024, According to Top Analysts
- Elevance Health price target lowered to $551 from $643 at Morgan Stanley
- Elevance Health price target lowered to $549 from $665 at Bernstein